Literature DB >> 14684849

Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions.

Ben E Black1, Michael J Vitto, Daniel Gioeli, Adam Spencer, Nima Afshar, Mark R Conaway, Michael J Weber, Bryce M Paschal.   

Abstract

Here we report that mutations within the DNA-binding domain of AR, shown previously to inhibit nuclear export to the cytoplasm, cause an androgen-dependent defect in intranuclear trafficking of AR. Mutation of two conserved phenylalanines within the DNA recognition helix (F582, 583A) results in androgen-dependent arrest of AR in multiple subnuclear foci. A point mutation in one of the conserved phenylalanines (DeltaF582, F582Y) is known to cause androgen insensitivity syndrome (AIS). Both AIS mutants (DeltaF582, F582Y) and the export mutant (F582, 583A) displayed androgen-dependent arrest in foci, and all three mutants promoted androgen-dependent accumulation of the histone acetyl transferase CREB binding protein (CBP) in the foci. The foci correspond to a subnuclear compartment that is highly enriched for the steroid receptor coactivator glucocorticoid receptor-interacting protein (GRIP)-1. Agonist-bound wild-type AR induces the redistribution of GRIP-1 from foci to the nucleoplasm. This likely reflects a direct interaction between these proteins because mutation of a conserved residue within the major coactivator binding site on AR (K720A) inhibits AR-dependent dissociation of GRIP-1 from foci. GRIP-1 also remains foci-associated in the presence of agonist-bound F582, 583A, DeltaF582, or F582Y forms of AR. Two-dimensional phospho-peptide mapping and analysis with a phospho-specific antibody revealed that mutant forms of AR that arrest in the subnuclear foci are hypophosphorylated at Ser81, a site that normally undergoes androgen-dependent phosphorylation. Our working model is that the subnuclear foci are sites where AR undergoes ligand-dependent engagement with GRIP-1 and CBP, a recruitment step that occurs before Ser81 phosphorylation and association with promoters of target genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684849     DOI: 10.1210/me.2003-0145

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

1.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function.

Authors:  Lin Lin; Pascal Philibert; Bruno Ferraz-de-Souza; Daniel Kelberman; Tessa Homfray; Assunta Albanese; Veruska Molini; Neil J Sebire; Silvia Einaudi; Gerard S Conway; Ieuan A Hughes; J Larry Jameson; Charles Sultan; Mehul T Dattani; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

3.  Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.

Authors:  Joshua W Russo; Xiaming Liu; Huihui Ye; Carla Calagua; Sen Chen; Olga Voznesensky; James Condulis; Fen Ma; Mary-Ellen Taplin; David J Einstein; Steven P Balk; Shaoyong Chen
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

4.  Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

Authors:  Shaoyong Chen; Youyuan Xu; Xin Yuan; Glenn J Bubley; Steven P Balk
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

5.  Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor.

Authors:  Chun-Song Yang; Michael J Vitto; Scott A Busby; Benjamin A Garcia; Cristina T Kesler; Daniel Gioeli; Jeffrey Shabanowitz; Donald F Hunt; Kathleen Rundell; David L Brautigan; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Quantitative methods to analyze subnuclear protein organization in cell populations with varying degrees of protein expression.

Authors:  Ty C Voss; Ignacio A Demarco; Cynthia F Booker; Richard N Day
Journal:  J Biomed Opt       Date:  2005 Mar-Apr       Impact factor: 3.170

7.  Multiple exportins influence thyroid hormone receptor localization.

Authors:  Kelly S Subramanian; Rose C Dziedzic; Hallie N Nelson; Mary E Stern; Vincent R Roggero; Cornelius Bondzi; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2015-04-21       Impact factor: 4.102

8.  Identification of androgen receptor phosphorylation in the primate ovary in vivo.

Authors:  Iain J McEwan; Dagmara McGuinness; Colin W Hay; Robert P Millar; Philippa T K Saunders; Hamish M Fraser
Journal:  Reproduction       Date:  2010-04-20       Impact factor: 3.906

9.  Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.

Authors:  Heather L Montie; Maria S Cho; Latia Holder; Yuhong Liu; Andrey S Tsvetkov; Steven Finkbeiner; Diane E Merry
Journal:  Hum Mol Genet       Date:  2009-03-11       Impact factor: 6.150

10.  Expression of androgen receptor and its phosphorylated forms in breast cancer progression.

Authors:  Qinghu Ren; Liying Zhang; Rachel Ruoff; Susan Ha; Jinhua Wang; Shilpa Jain; Victor Reuter; William Gerald; Dilip D Giri; Jonathan Melamed; Michael J Garabedian; Peng Lee; Susan K Logan
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.